| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | 神經系統
> 多發性硬化症 | 監管合作夥伴關係
> 與監管機構合作 | 5,000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | 內分泌
> 糖尿病及高血壓 | 監管合作夥伴關係
> 與其他醫療倡導者 | 10,000 | National | Sometimes | 119045009637 |
| We are one of three founding members of the South African Non-Communicable Disease Association. | 內分泌
> 糖尿病及高血壓 | 監管合作夥伴關係
> 與其他醫療倡導者 | 10,000 | National | Sometimes | 119051187994 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | 神經系統
> 多發性硬化症 | 影響政策及立法
> 影響醫療保健政策及立法 | 5,000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | 癌症
> 癌症：大多數類型 | 影響政策及立法
> 影響醫療保健政策及立法 | 10,000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多數類型 | 影響政策及立法
> 參與公眾聆訊及諮詢 | 10,000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | 神經系統
> 多發性硬化症 | 定價及可負擔性倡議
> 倡導公平藥品定價 | 5,000 | Regional | Regularly | 119035905477 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | 風濕性
> 軸性脊椎關節炎 | 定價及可負擔性倡議
> 倡導公平藥品定價 | Over 100,000 | National | Regularly | 119051166861 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多數類型 | 定價及可負擔性倡議
> 參與價格審查委員會談判 | 10,000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多數類型 | 定價及可負擔性倡議
> 倡導將產品納入報銷清單／國家藥品目錄 | 10,000 | National | Regularly | 119044111428 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | 風濕性
> 軸性脊椎關節炎 | 定價及可負擔性倡議
> 倡導將產品納入報銷清單／國家藥品目錄 | Over 100,000 | National | Regularly | 119051166861 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | 神經系統
> 多發性硬化症 | 改善存取途徑
> 促進公平獲取藥物／醫療保健 | 5,000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | 癌症
> 癌症：大多數類型 | 改善存取途徑
> 促進公平獲取藥物／醫療保健 | 10,000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多數類型 | 以實證為基礎的患者意見
> 利用患者洞察來輔助決策 | 10,000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | 神經系統
> 多發性硬化症 | 以實證為基礎的患者意見
> 向監管機構提供真實世界證據（RWE） | 5,000 | Regional | Regularly | 119035905477 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. Our input is informed by lived experience, patient-reported challenges, and international collaboration through global MS networks, ensuring that patient needs, equity, and sustainability are considered in decision-making processes. | 神經系統
> 多發性硬化症 | 以實證為基礎的患者意見
> 善用患者故事及親身經歷敘述 | 5,000 | Regional | Regularly | 119035905477 |
| Have engaged the Department of Health. | 罕見
> 罕見疾病：免疫 | 機構管治
> 確保在政府諮詢機構中獲得代表席位 | 100 | International | Rarely | 119036013383 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | 神經系統
> 多發性硬化症 | 機構管治
> 在多方持份者網絡中有效運作 | 5,000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | 內分泌
> 糖尿病及高血壓 | 機構管治
> 維持公益或慈善機構的正式地位 | 10,000 | National | Sometimes | 119045009637 |
互動
行動與倡議
3 提及
